HomeAnnual Reports to Congress on the President’s Emergency Plan for AIDS Relief ...PEPFAR 2014 Annual Report Supplemental Tables hide PEPFAR 2014 Annual Report Supplemental Tables The United States President’s Emergency Plan for AIDS Relief Prevention: Direct FY2013 Prevention of Mother-to-Child Transmission Program Results Countries Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results)1 Number of HIV+ pregnant women receiving ARV prophylaxis Estimated infant HIV infections averted2 Angola 83,000 1,000 300 Botswana3 NA NA NA Burma3 NA NA NA Burundi 128,300 1,000 300 Cambodia 80,800 200 58 Cameroon 83,400 4,000 1,200 Côte d’Ivoire 470,700 13,200 4,000 Democratic Republic of the Congo 313,200 4,600 1,400 Dominican Republic 62,900 200 49 Ethiopia 1,390,800 18,300 5,600 Ghana3 NA NA NA Guyana 10,600 48 15 Haiti 236,200 5,000 1,500 India3 NA NA NA Indonesia3 NA NA NA Kenya 1,245,700 55,100 15,800 Lesotho 27,100 7,700 2,400 Malawi 469,700 35,700 10,900 Mozambique 930,500 88,500 26,300 Namibia 55,200 4,300 1,300 Nigeria 1,808,500 46,500 13,900 Papua New Guinea3 NA NA NA Russia3 NA NA NA Rwanda 150,300 4,300 1,300 South Africa 913,400 222,100 68,000 South Sudan 16,500 700 200 Swaziland 26,600 9,500 2,900 Tanzania 1,425,100 55,600 17,000 Uganda 1,508,400 88,300 27,000 Ukraine3 NA NA NA Vietnam 358,600 1,300 400 Zambia 530,100 54,700 16,400 Zimbabwe 457,400 59,200 17,600 Regions Asia Region3 NA NA NA Caribbean Region3 NA NA NA Central America3 NA NA NA Central Asia3 NA NA NA Total 12,783,000 781,048 235,822 Notes: All numbers greater than 100 have been rounded off to the nearest 100. All results reflect accomplishments through September 30, 2013. Footnotes: 1This indicator has two components: 1) the number of women with known positive HIV infection attending an ANC for a new pregnancy over the last reporting period; and 2) the number of women attending ANC, Labor and Delivery sites who were tested for HIV and received results (which is also captured under the testing and counseling results). The previous PMTCT indicator: “the number of pregnant women receiving PMTCT services” included only women who were counseled and tested and received their test results. For further information, refer to Indicator P1.1.D in the PEPFAR Next Generation Indicator Reference Guide Version 1.2 on http://www.pepfar.gov/reports/guidance/c21628.htm. 2PEPFAR PMTCT country programs report PMTCT ARV uptake by regimen (ART for HIV-positive pregnant women eligible for treatment, maternal AZT, maternal triple ARV prophylaxis, and single dose nevirapine). The method used to estimate infant HIV infections averted now accounts for the different probabilities of transmission for each of the different regimens. 3“NA” refers to countries or regions where USG did not support or did not directly support PMTCT or PMTCT ARV prophylaxis programs. Prevention: Direct FY2013 Testing and Counseling Results Countries Number of individuals 1 Angola 158,900 Botswana 131,000 Burma 11,100 Burundi 374,900 Cambodia 202,500 Cameroon 117,300 Côte d’Ivoire 1,111,300 Democratic Republic of the Congo 603,600 Dominican Republic 65,400 Ethiopia 8,069,500 Ghana 93,300 Guyana 19,900 Haiti 839,000 India 20,300 Indonesia 25,000 Kenya 8,790,800 Lesotho 138,900 Malawi 1,746,400 Mozambique 2,745,800 Namibia 315,100 Nigeria 6,675,000 Papua New Guinea 1,800 Russia NA Rwanda 1,690,800 South Africa 6,617,300 South Sudan 60,100 Swaziland 249,800 Tanzania 5,187,000 Uganda 7,451,900 Ukraine 29,900 Vietnam 602,000 Zambia 2,317,400 Zimbabwe 1,073,100 Regions Asia Region 24,000 Caribbean Region 84,200 Central America 61,200 Central Asia2 NA Total 57,705,500 Note: All numbers greater than 100 have been rounded off to the nearest 100. All results reflect accomplishments through September 30, 2013. Footnotes: 1This indicator includes individuals who received testing and counseling services for HIV and received their test results from any service delivery point during the 12 months. Service delivery points include fixed health care facilities such as: hospitals, public and private clinics, voluntary counseling and testing sites, antenatal clinics, labor and delivery sites, PMTCT, or TB sites; standalone sites such as free-standing sites not associated with medical institutions; and mobile testing such as HIV T&C services offered in a specific location for a limited period of time, e.g. outreach, door-to-door services and workplace testing programs. For further information, refer to Indicator P11.1.D in the PEPFAR Next Generation Indicator Reference Guide Version 1.2 on http://www.pepfar.gov/reports/guidance/c21628.htm. 2“NA” refers to countries or regions where USG did not support T&C programs. Treatment: Direct FY2013 Voluntary Male Medical Circumcision Results Countries Number of individuals Angola1 NA Botswana 12,500 Burma NA Burundi1 NA Cambodia1 NA Cameroon1 NA Côte d’Ivoire2 NA Democratic Republic of the Congo1 NA Dominican Republic1 NA Ethiopia 16,400 Ghana1 NA Guyana1 NA Haiti1 NA India1 NA Indonesia1 NA Kenya 214,900 Lesotho 36,400 Malawi 67,400 Mozambique 129,600 Namibia1 NA Nigeria1 NA Papua New Guinea1 NA Russia1 NA Rwanda 36,400 South Africa 295,000 South Sudan1 NA Swaziland 9,700 Tanzania 381,400 Uganda 743,000 Ukraine1 NA Vietnam1 NA Zambia 199,400 Zimbabwe 88,100 Regions Asia Region1 NA Caribbean Region1 NA Central America1 NA Central Asia1 NA Total 2,230,200 Notes: All numbers greater than 100 have been rounded off to the nearest 100. The number of individuals is as of September 30, 2013. Footnotes: 1“NA” refers to countries where USG did not directly support voluntary male medical circumcision programs. Treatment: Direct FY2013 Antiretroviral Treatment Results Countries Number of individuals Angola1 NA Botswana 5,600 Burma1 NA Burundi1 NA Cambodia 9,800 Cameroon1 NA Côte d’Ivoire 95,000 Democratic Republic of the Congo 14,800 Dominican Republic 1,200 Ethiopia 317,400 Ghana1 NA Guyana 2,900 Haiti 52,000 India1 NA Indonesia1 NA Kenya 631,500 Lesotho 91,800 Malawi 348,000 Mozambique 365,100 Namibia 61,600 Nigeria 538,000 Papua New Guinea 200 Russia1 NA Rwanda 76,000 South Africa 2,513,900 South Sudan 6,300 Swaziland 69,000 Tanzania 444,400 Uganda 507,700 Ukraine1 NA Vietnam 43,900 Zambia 503,400 Zimbabwe 140,000 Regions Asia Region 1,300 Caribbean Region1 NA Central America1 NA Central Asia1 NA Total2 6,840,800 Notes: All numbers greater than 100 have been rounded off to the nearest 100. All results reflect accomplishments through September 30, 2013. Footnotes: 1“NA” refers to countries where USG did not directly support treatment programs. 2Due to country updates, the total results are slightly higher than the reported results in the 2013 World AIDS Day FACT Sheet. All results still reflect accomplishments through September 30, 2013. Treatment: Direct FY2013 Number of Women and Children Receiving Antiretroviral Treatment Treatment: Direct FY2013 Number of Women and Children Receiving Antiretroviral Treatment1 Females (all ages)2 Children (ages 0-14) Total3 4,359,897 (64%) 506,604 (7%) Notes: All numbers greater than 100 have been rounded off to the nearest 100. Footnotes: 1The percentages represent the share of all individuals receiving treatment who were women and children (<15 years), respectively. 2Of this reported number of female (all ages), 261,297 were female children (0-14). 3Due to several country updates, the total results are slightly higher than the reported results in the PEPFAR Blueprint. All results still reflect accomplishments through September 30, 2013. Care: Direct FY2013 Care and Support Results Countries Number of individuals 1 Angola2 NA Botswana 40,100 Burma 600 Burundi 22,600 Cambodia 56,500 Cameroon 6,800 Côte d’Ivoire 353,300 Democratic Republic of the Congo 45,500 Dominican Republic 17,300 Ethiopia 1,307,900 Ghana 61,500 Guyana 5,600 Haiti 200,700 India 700 Indonesia 3,500 Kenya 1,381,900 Lesotho 150,900 Malawi 765,100 Mozambique 876,100 Namibia 192,000 Nigeria 2,741,600 Papua New Guinea 200 Russia2 NA Rwanda 268,200 South Africa 3,886,600 Sudan 20,200 Swaziland 196,200 Tanzania 990,600 Uganda 1,147,300 Ukraine 1,900 Vietnam 80,700 Zambia 1,626,000 Zimbabwe 537,400 Regions Asia Region 4,900 Caribbean Region 2100 Central America2 NA Central Asia 3,100 Total 16,995,600 Notes: All numbers greater than 100 have been rounded off to the nearest 100. All results reflect accomplishments through September 30, 2013. Footnotes: 1 This is the total care indicator which includes adults and children (including orphans and vulnerable children (OVC)) provided with a minimum of one care service in the past 12 months. PEPFAR care programs include support, preventative, and clinical services. For further information, refer to Indicator C1.1.D in the PEPFAR Next Generation Indicator Reference Guide Version 1.2 on http://www.pepfar.gov/reports/guidance/c21628.htm. 2“NA” refers to countries or regions where USG did not support care programs. Care: Direct FY2013 Orphans and Vulnerable Children Results Countries Number of orphans and vulnerable children1 Angola2 NA Botswana 16,900 Burma2 NA Burundi 13,700 Cambodia 25,500 Cameroon 80 Côte d’Ivoire 142,000 Democratic Republic of the Congo 16,900 Dominican Republic 1,700 Ethiopia 648,500 Ghana 5,300 Guyana 1,300 Haiti 35,100 India 42 Indonesia 100 Kenya 658,600 Lesotho 56,100 Malawi 272,400 Mozambique 229,100 Namibia 43,700 Nigeria 739,300 Papua New Guinea2 NA Russia2 NA Rwanda 88,500 South Africa 558,400 Sudan 2,100 Swaziland 62,800 Tanzania 329,700 Uganda 357,300 Ukraine2 NA Vietnam 9,900 Zambia 479,200 Zimbabwe 245,400 Regions Asia Region 1,100 Caribbean Region2 NA Central America2 NA Central Asia2 NA Total 5,040,722 Notes: All numbers greater than 100 have been rounded off to the nearest 100. All results reflect accomplishments through September 30, 2013. Footnotes: 1The number of orphans and vulnerable children (OVC) includes all individuals <18 years reported as a subset of the total number of individuals provided with a minimum of one care service. For further information, refer to Indicator C1.1.D in the PEPFAR Next Generation Indicator Reference Guide Version 1.2 on http://www.pepfar.gov/reports/guidance/c21628.htm.. 2 “NA” refers to countries where USG did not support OVC programs.
